MagScrew TAH: an update.
MagScrew TAH: an update.
复制标题
MagScrew TAH:更新。
DOI:
10.1097/01.mat.0000187395.29817.36
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Prisco
中科院分区:
文献类型:
--
作者:
Weber,Stephan;Kamohara,Keiji;Klatte,RyanS;Luangphakdy,Viviane;Flick,Christine;Chen,Ji-Feng;Casas,Fernando;Ootaki,Yoshio;Kopcak,Michael;Akiyama,Masatoshi;Hirschman,GordonB;Chapman,PeterA;Donahue,Arthur;Wetterau,William;Prisco
Purpose:A passively filling, 45 ml stroke volume MagScrew Total Artificial Heart (TAH) system was tested in-vitro and in-vivo. Focus of the in-vitro experiments was the demonstration of preload and afterload sensitivity, atrial balance and flow capabilities. Goal of the in-vivo studies was the demonstration of blood/biocompatibility of all implanted system components and exercise tolerance on a treadmill.Methods:The in-vitro studies utilized a mock circulation, evaluating device performance in fixed rate and automatic control mode. The in-vivo experiments were conducted in calves. The TAH system was operated in automatic control mode.Results:In-vitro tests showed excellent preload sensitivity resulting in device flows above 10 L/Min at a beat rate of 220 BPM, at a systemic mean afterload of 100 mm Hg and a left atrial pressure of 13 mm Hg. Atrial balance was maintained at all tested conditions. Separate tests demonstrated low afterload sensitivity and a device flow of up to 14 L/min at beat rates of up to 280 BPM. Four in-vivo studies with durations between 4-83 days confirmed the in-vitro results with average flows ranging between 8.7–10.4 L/min at average beat rates ranging between 204–224 BPM. Hemodynamics remained normal with excellent left right atrial balance throughout the course of each experiment. Hemolysis was not detected in any animal. End-organ function was well maintained without thromoembolic events. The exercise tolerance of all animals was good, without signs of anaerobic metabolism.